Evaxion Biotech A/S (EVAX)
NASDAQ·Healthcare·Biotechnology
$3.31
-3.24%
Mkt Cap $19.45M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$10.50
Range $10.00 – $11.00
Implied Upside
+217.3%
Consensus $10.50 vs current $3.31
NASDAQ·Healthcare·Biotechnology
$3.31
-3.24%
Mkt Cap $19.45M
No recent rating data.
Price Target (3 analysts)
$10.50
Range $10.00 – $11.00
+217.3%
Consensus $10.50 vs current $3.31